Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports describe recent advances in breast cancer research
January 27th, 2005
Data on breast cancer are outlined in reports from the United States. Study 1: CD8+ cytotoxic T lymphocytes from breast cancer patients recognize HLA-A2-restricted mammaglobin-A-derived epitopes. "A breast cancer-associated antigen, mammaglobin-A, is specifically expressed in 80% of primary breast tumors. The definition of immune responses against this highly expressed breast cancer-specific antigen should be of great value in the development of new therapeutic strategies for breast cancer. Thus, the purpose of this study was to identify HLA-A2-restricted mammaglobin-A- derived epitopes recognized by CD8+ cytotoxic T lymphocytes (CTL). We identified...
Source: Women's Health Weekly (2005-01-27)
|
